Vimarsana
Biggest News Aggregation in the World

Page 3 - Fran Gregory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fran Gregory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fran Gregory Today - Breaking & Trending Today

Expert Reflects on Trends, US Market of Biosimilars in 2023 - Vimarsana News

Expert Reflects on Trends, US Market of Biosimilars in 2023

Fran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health, discusses the dynamic landscape of the biosimilars market, providing key insights into its current status and future projections.

The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs - Vimarsana News

The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs

Perhaps the most significant development in the pharmaceutical industry in decades, crops of biosimilars are being approved and are ready for distribution. What lies next, in terms of legislation and the impact on pharmacists, remains to be seen.

Biosimilars Require Standardization of Knowledge in the Field - Vimarsana News

Biosimilars Require Standardization of Knowledge in the Field

A panel of experts discuss the state of biosimilars today and the importance of standardizing knowledge of the field.

Biosimilar makers split strategies in bid to take on top-selling Humira - Vimarsana News

Biosimilar makers split strategies in bid to take on top-selling Humira

BioPharma

Expert: Though Patients Don't Always See Savings With Biosimilars, New Policies Could Improve Access - Vimarsana News

Expert: Though Patients Don't Always See Savings With Biosimilars, New Policies Could Improve Access

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access.